Structural and chemical aspects of HPMA copolymers as drug carriers
- PMID: 19931329
- DOI: 10.1016/j.addr.2009.10.007
Structural and chemical aspects of HPMA copolymers as drug carriers
Abstract
Synthetic strategies and chemical and structural aspects of the synthesis of HPMA copolymer conjugates with various drugs and other biologically active molecules are described and discussed in this chapter. The discussion is held from the viewpoint of design and structure of the polymer backbone and biodegradable spacer between a polymer and drug, structure and methods of attachment of the employed drugs to the carrier and structure and methods of conjugation with targeting moieties. Physicochemical properties of the water-soluble polymer-drug conjugates and polymer micelles including mechanisms of drug release are also discussed. Detailed description of biological behavior of the polymer-drug conjugates as well as application of the copolymers for surface modification and targeting of gene delivery vectors are not included, they are presented and discussed in separate chapters of this issue.
Copyright 2009 Elsevier B.V. All rights reserved.
Similar articles
-
HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.J Control Release. 2009 Nov 16;140(1):18-26. doi: 10.1016/j.jconrel.2009.07.011. Epub 2009 Jul 24. J Control Release. 2009. PMID: 19632282
-
New perspectives of HPMA-based copolymers derived by post-polymerization modification.Macromol Biosci. 2014 May;14(5):607-18. doi: 10.1002/mabi.201400028. Epub 2014 Mar 19. Macromol Biosci. 2014. PMID: 24644097
-
Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.Adv Drug Deliv Rev. 2010 Feb 17;62(2):246-57. doi: 10.1016/j.addr.2009.12.007. Epub 2010 Jan 7. Adv Drug Deliv Rev. 2010. PMID: 20060431 Review.
-
HPMA copolymer-cyclic RGD conjugates for tumor targeting.Adv Drug Deliv Rev. 2010 Feb 17;62(2):167-83. doi: 10.1016/j.addr.2009.11.027. Epub 2009 Dec 4. Adv Drug Deliv Rev. 2010. PMID: 19951733 Review.
-
Self-association properties of HPMA copolymers containing an amphipathic heptapeptide.J Drug Target. 2007 Aug-Sep;15(7-8):465-74. doi: 10.1080/10611860701500016. J Drug Target. 2007. PMID: 17671893
Cited by
-
Fluorescence Imaging as a Tool in Preclinical Evaluation of Polymer-Based Nano-DDS Systems Intended for Cancer Treatment.Pharmaceutics. 2019 Sep 12;11(9):471. doi: 10.3390/pharmaceutics11090471. Pharmaceutics. 2019. PMID: 31547308 Free PMC article. Review.
-
Impact of the nature and size of the polymeric backbone on the ability of heterobifunctional ligands to mediate shiga toxin and serum amyloid p component ternary complex formation.Toxins (Basel). 2011 Sep;3(9):1065-88. doi: 10.3390/toxins3091065. Epub 2011 Aug 25. Toxins (Basel). 2011. PMID: 22069757 Free PMC article.
-
Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer.Pharmaceutics. 2022 Nov 10;14(11):2432. doi: 10.3390/pharmaceutics14112432. Pharmaceutics. 2022. PMID: 36365249 Free PMC article. Review.
-
Biological rationale for the design of polymeric anti-cancer nanomedicines.J Drug Target. 2013 Jan;21(1):1-26. doi: 10.3109/1061186X.2012.723213. Epub 2012 Sep 26. J Drug Target. 2013. PMID: 23009337 Free PMC article. Review.
-
Advanced architectures in the design of responsive polymers for cancer nanomedicine.J Appl Polym Sci. 2018 Jun 20;135(24):46154. doi: 10.1002/app.46154. Epub 2018 Jan 31. J Appl Polym Sci. 2018. PMID: 30174339 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources